Drugs / Meperidine

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) DEMEROL — 1942-11-10 fda.gov ↗

Trials 12

19411942194319441945194619471948194919501951195219531954195519561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01236651 Nov 2010 → Apr 2011 — Ain Shams University Unknown No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT03260283 Aug 2017 → Nov 2018 — Saint Savvas Anticancer Hospital Completed No outcome recorded
Phase 32 trials
Phase 3 NCT05126459 Feb 2022 → Apr 2023 anxiety, dental caries Loma Linda University Completed No outcome recorded
Phase 3 NCT00163553 Dec 2004 → ? sciatica Austin Health Unknown No outcome recorded
Phase 43 trials · 1 met primary
Phase 4 NCT05110469 Feb → Jun 2021 benign shuddering attacks AnestesiaR Completed No outcome recorded
Phase 4 NCT02486328 May → Jun 2015 cognitive disorder, digestive system disorder Ufuk University Completed Met primary
Phase 4 NCT00596414 May 2003 → Oct 2005 anxiety, cirrhosis of liver, hepatitis Erasme University Hospital Completed No outcome recorded
Phase not applicable5 trials · 2 met primary
— NCT04446715 Oct 2020 → Aug 2021 — Makassed General Hospital Unknown Met primary
— NCT01741259 Aug 2013 → Apr 2015 — Mercy Research Completed No outcome recorded
— NCT01840371 Apr 2013 → Mar 2014 — Yonsei University Completed No outcome recorded
— NCT01547520 Jun 2011 → Feb 2012 — Dalin Tzu Chi General Hospital Completed Met primary
— NCT00296751 Mar → Dec 2006 — Rambam Health Care Campus Completed No outcome recorded
Comparator or background therapy80 trials
Phase 0 NCT07711522 Background Aug 2026 → Jul 2027 expected — Istanbul Medipol University Hospital Not yet recruiting No outcome recorded
Phase 1 NCT05035407 Background Mar 2022 → Jul 2025 — National Cancer Institute (NCI) Terminated No outcome recorded
Phase 1 NCT02867800 Background Jul 2016 → Dec 2021 graft versus host disease, sickle cell disease Monica Bhatia Completed No outcome recorded
Phase 1/2 NCT02858310 Background Jan 2017 → Jul 2025 cervical intraepithelial neoplasia, human papilloma virus infection, in situ carcinoma, vulvar neoplasm National Cancer Institute (NCI) Completed No outcome recorded
Phase 2 NCT06326944 Comparator Apr → Sep 2024 — Kasr El Aini Hospital Completed No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 92 sources stand behind the page.

FieldValueCited text
Known as meperidine “If the NRS score is ≥ 4, 0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT06546839 ↗
46

“If the NRS score is ≥ 4, 0.5 mg kg-1 IV meperidine will be administered as a rescue analgesic.” NCT07278050 ↗

“If the NRS score is ≥ 4, 0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT05904912 ↗

“If the NRS score is ≥ 4, 0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT05972122 ↗

“Group P (n =80) will receive pethidine (meperidine) 0.5 mg/kg i.v. (Ampoules of 50 mg/1 ml).” NCT06627816 ↗

“Intravenous meperidine administration at 0.5 mg / kg rescue analgesia was determined” NCT03413163 ↗

“Hydroxyzine (1.5- 2mg/kg) + Meperidine (1.5 -2 mg/kg) + Midazolam (0.5- 0.75 mg/kg)” NCT05126459 ↗

“If the VAS score will be ≥ 4, 0,5 mg/kg-1 meperidine IV will be administered.” NCT05621161 ↗

“Meperidine 25-50 mg IVPB every 4 hours will be given as needed for rigors.” NCT03456817 ↗

“0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT06866054 ↗

“0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT05566561 ↗

Show 36 more sources

Known as Demerol ClinicalTrials.gov intervention name — accepted as the source's own label NCT01997788 ↗
Known as pethidine “Group P (n =80) will receive pethidine (meperidine) 0.5 mg/kg i.v. (Ampoules of 50 mg/1 ml).” NCT06627816 ↗
44

“fentanyl based patient-controlled analgesia + additional pethidine for postoperative 48 hour” NCT02012244 ↗

“intravenous paracetamol( 1gram ) and pethidine IV (50 mg ) will be added when needed.” NCT03422354 ↗

“Postoperatively pethidine 50 mg IV will be administered for VAS score greater than 4” NCT07299630 ↗

“The forth group consisted of 25 participants receiving 100 mg pethidine.” NCT01993589 ↗

“then intravenous pethidine till 48 hours after surgery” NCT03866733 ↗

“Group P received pethidine 50 mg IV.” NCT03780556 ↗

“intravenous pethidine 0.25 mg/kg” NCT04133571 ↗

“"Meperidine" (pethidine®)” NCT02475824 ↗

NCT02619019 ↗

NCT04744727 ↗

Show 34 more sources

Known as pethidine HCL “Meperidine (50mg. 25mg for patients aged ≥70 years; pethidine HCL, Hana Pharm Co., Seoul, Republic of Korea).” NCT02475824 ↗
Known as Pethidine Hydrochloride “Pethidine Hydrochloride 50 Mg/mL Solution for Injection” NCT06775431 ↗
2

NCT01558622 ↗

NCT01858090 ↗

Action Activate “Pethidine is one of the most frequently used opiate agonists.” NCT02783508 ↗
Modality Small molecule “synthetic opioid analgesic” NCT01558622 ↗
Route Other “continuous infusion of epidural pethidine through a surgically-placed catheter” NCT00163553 ↗